HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples [NA]
This completed trial evaluated the effectiveness of a risk reduction program in preventing transmission of HIV and sexually transmitted dise…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1 [Phase 2]
A Phase 2 trial comparing different doses of UK-453,061 plus Truvada to Efavirenz plus Truvada in treatment-naive HIV-1 patients; the study …
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: A Case Management Intervention to Prevent ER Visits in HIV-infected Persons [NA]
This entry reports the termination of a clinical trial evaluating a case management intervention aimed at reducing emergency department visi…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. [Phase 3]
A Phase 3 randomized trial evaluating whether a once-daily protease inhibitor regimen is non-inferior to the current twice-daily regimen in …
-
CLINICAL_TRIALS research · 2014-01-22Clinical Trial Update: Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection [NA]
This record notes the completion of a University of Miami–sponsored clinical trial evaluating strategies to promote male involvement to impr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-01-22Clinical Trial Update: Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive [Phase 1]
Phase 1 safety study of the Modified Vaccinia Ankara (MVA) smallpox vaccine in HIV-positive, vaccinia-naive individuals; the trial sponsored…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Comparison of HIV Testing Algorithms
This clinical trial update reports the completion of a study comparing HIV testing algorithms. The trial did not involve a pharmacologic tre…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Kidney and Liver Transplantation in People With HIV
Clinical trial update on kidney and liver transplantation in people with HIV has completed. The study evaluated transplantation outcomes in …
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen [Phase 4]
Phase 4 clinical trial update evaluating two second-line combination antiretroviral therapy options after virological failure of a standard …
-
CLINICAL_TRIALS withdrawal · 2014-01-16Clinical Trial Update: RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) [Phase 1]
A Phase 1 trial of RHIV for HIV infections refractory or intolerant to HAART has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients [Phase 1, Phase 2]
A dose-escalation Phase 1/2 trial of tenofovir alafenamide in treatment-naive HIV patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Vacc-C5 with adjuvants GM-CSF or Alhydrogel in HIV-1-infected subjects on ART has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Shaping the Health of Adolescents in Zimbabwe [NA]
The clinical trial studying the health of adolescents in Zimbabwe with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
This document reports an expanded-access study of the oral liquid form of efavirenz for children with HIV infection. The trial is no longer …
-
CLINICAL_TRIALS research · 2014-01-09Clinical Trial Update: An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
Canada-based expanded-access study of oral liquid efavirenz for children with HIV infection; the study is no longer available.
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
This citation notes the completion of a study evaluating physical and metabolic abnormalities in HIV-infected and uninfected children and yo…
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: HIV Prevention Preparedness Study in Russia, China, and India
A completed clinical trial update for an HIV prevention preparedness study conducted in Russia, China, and India, sponsored by the National …
-
FDA approval · 2014-01-02FDA Approved: LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic lamivudine tablet under an Original Application (ANDA). Lamivudine is used to treat HIV-1 infec…
-
FDA approval · 2014-01-02FDA Approved: LAMIVUDINE — Original Application (Apotex Corp.)
FDA approves Apotex Corp.'s original application for a generic lamivudine product (ANDA 202941). The generic is approved for the same indica…
-
FDA approval · 2013-12-20FDA Approved: ISENTRESS — Original Application (Merck Sharp & Dohme LLC)
The FDA approved the original application for Isentress (raltegravir) from Merck for treatment of HIV-1 infection in adults and pediatric pa…
-
FDA approval · 2013-12-20FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Improving Treatment Adherence in HIV-Infected Individuals [Phase 2]
Phase 2 trial update evaluating strategies to improve treatment adherence in HIV-infected individuals; results were posted after completion.
-
FDA approval · 2013-12-19FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (Zidovudine) from ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: RAltegravir Switch STudy: Effects on Endothelial Recovery [Phase 4]
Phase 4 clinical trial update evaluating switching to raltegravir and its effect on endothelial recovery in HIV-infected individuals. The st…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
This clinical trial update notes the completion of a study evaluating immune reconstitution in patients with advanced HIV-1 infection.